Form 4: Nuvation Bio Inc. Director Kim D. Blickenstaff Increases Stake in Company
SEC Form 4 Filing
Director Kim D. Blickenstaff purchased 172,189 shares of Nuvation Bio Inc. at an average price of $2.9043 on June 11, 2024.
Summary
- On June 11, 2024, Kim D. Blickenstaff, a director of Nuvation Bio Inc., acquired 172,189 shares of Class A Common Stock.
- The shares were purchased at a weighted-average price of $2.9043, with individual prices ranging from $2.835 to $2.96.
- Following the transaction, Blickenstaff beneficially owns 172,189 shares through a revocable trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's performance.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| April 15, 2010 | Date of the Kim Blickenstaff Revocable Trust |
| June 11, 2024 | Date of the stock purchase transaction |
| June 13, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.